Form 4: Orthopediatrics Corp. Director Ruf Harold Reports Acquisition of Shares
SEC Form 4 Filing
Director Ruf Harold reports acquiring 2,766 shares of Orthopediatrics Corp. common stock on May 28, 2024.
Summary
- On May 28, 2024, Ruf Harold, a director of Orthopediatrics Corp., acquired 2,766 shares of common stock.
- The acquisition was direct and the price was $0.
- Following the transaction, Ruf Harold directly owns 6,326 shares of common stock.
- Additionally, Ruf Harold indirectly owns 15,321 shares through the Last Chance Legacy Trust, dated April 3, 2023, where he serves as trustee.
- These shares include 4,640 restricted stock awards.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director. The acquisition itself can be seen as slightly positive, indicating confidence, but the filing is primarily informational.
Positives
- The director's acquisition of shares could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.
Stakeholder Impact
- The acquisition of shares by a director may positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| April 3, 2023 | Date of the Last Chance Legacy Trust |
| May 28, 2024 | Date of the stock acquisition |
| May 30, 2024 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.